Delivery Order SPE2DB22D3301-SPE2DB25FX9QR

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,200.65 Firm Fixed Price delivery order contract is for the supply of CLOMID 50 MG TABLET UD 30S, a generic prescription medication. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,224.55, is a delivery order for 4566798954 - CLOMID 50 MG TABLET UD 10S. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $12,885.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566420447 CLOMID 50 MG TABLET UD 30S, with a completion date of November 14, 2024. The contract is a Firm Fixed Price agreement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,879.56 firm fixed-price delivery order is for the supply of CLOMID 50 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of January 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,873.70 firm fixed-price delivery order is for the provision of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award ceiling value of $1,799.73 and is a firm fixed-price delivery order for the supply of 4563651892 CLOMID 50 MG TABLET UD 30S. The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,058.24 firm-fixed-price delivery order contract is for the supply of CLOMID 50 MG TABLET UD 30S medical products. The contract has an ultimate completion date of February 11, 2025 and was awarded on February 10, 2025. In addition to this specific delivery order, AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of CLOMID 50 MG TABLET UD 30S, a prescription medication. The contract, valued at $2,347.49, was awarded by the Defense Logistics Agency (DLA) on December 23, 2024, with a completion date of December 24, 2024. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,179.02 firm fixed-price delivery order covers the supply of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product, with a performance period through March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,967.42 firm fixed-price delivery order is for the supply of CLOMID 50 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX9QR
    Delivery Order

This federal contract award, valued at $2,321.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for CLOMID 50 MG TABLET UD 30S, with a completion date of February 6, 2025. The contract type is Firm Fixed Price, and there was no set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:30 AM